HomeRAPH • OTCMKTS
add
Raphael Pharmaceutical Inc
Previous close
$1.40
Year range
$0.15 - $1.40
Market cap
27.48M USD
Avg Volume
30.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 251.00K | -21.32% |
Net income | -255.00K | 21.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.00K | -92.50% |
Total assets | 7.00K | -86.27% |
Total liabilities | 1.27M | 90.55% |
Total equity | -1.26M | — |
Shares outstanding | 19.63M | — |
Price to book | -23.33 | — |
Return on assets | -3,391.89% | — |
Return on capital | 56.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -255.00K | 21.78% |
Cash from operations | -17.00K | 78.75% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -17.00K | 78.75% |
Free cash flow | 39.62K | -6.21% |
About
Founded
2007
Website
